Development of the Patient Satisfaction with Medication for Diabetes (PSMD) questionnaire
Kristina S. Boye·Chisom Kanu·Louis S. Matza·Danielle Soucier-Ernst·Christy R. Houle·Iris Goetz·Hiren N. Patel·Katie D. Stewart
Recent advances in treatment for type 1 (T1D) and type 2 diabetes (T2D) may have an impact on patients’ treatment satisfaction, which can affect adherence and outcomes. Established patient-reported outcome (PRO) measures of treatment satisfaction may not be sensitive to the treatment attributes and outcomes that are relevant and important to patients receiving new diabetes medications. The purpose of this study was to develop a new PRO measure to assess treatment satisfaction that would be relev